Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...

The Molecular Diagnostics - Infectious Disease market offers opportunities driven by multiplex testing, biotechnology advances, and rapid testing. Factors such as pathogen evolution, globalization, ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the results of its qualitative and quantitative "Analysis of Professional ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Harrisburg, NC---- 10/21/2020-- The Molecular Diagnostics Devices And Equipment Market report is a valuable source of insightful data for business strategists. The global molecular diagnostics devices ...

Becton, Dickinson and Company BDX, also popularly known as BD, recently announced the receipt of Emergency Use Authorization (EUA) from the FDA for a new combination molecular diagnostic test to ...

Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...

Over the past few months, the Molecular Diagnostics market has been prospering well on the back of the COVID-19 havoc, followed by the surge in Monkeypox cases. Apart from these instances, the niche ...